144 related articles for article (PubMed ID: 26377323)
21. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
22. EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.
Cai MY; Tong ZT; Zheng F; Liao YJ; Wang Y; Rao HL; Chen YC; Wu QL; Liu YH; Guan XY; Lin MC; Zeng YX; Kung HF; Xie D
Gut; 2011 Jul; 60(7):967-76. PubMed ID: 21330577
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
[TBL] [Abstract][Full Text] [Related]
24. Twist Expression in Pleomorphic Adenoma, Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of Salivary Glands.
Pardis S; Zare R; Jaafari-Ashkavandi Z; Ashraf MJ; Khademi B
Turk Patoloji Derg; 2016; 32(1):15-21. PubMed ID: 26832177
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of fine needle aspiration cytology for high-grade salivary gland tumors.
Kim BY; Hyeon J; Ryu G; Choi N; Baek CH; Ko YH; Jeong HS
Ann Surg Oncol; 2013 Jul; 20(7):2380-7. PubMed ID: 23440550
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Matsika A; Srinivasan B; Day C; Mader SA; Kiernan DM; Broomfield A; Fu J; Hooper JD; Kench JG; Samaratunga H
Pathology; 2015 Dec; 47(7):622-8. PubMed ID: 26517640
[TBL] [Abstract][Full Text] [Related]
27. Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma: a comparative study and review of the literature.
Xu B; Abourbih S; Sircar K; Kassouf W; Mansure JJ; Aprikian A; Tanguay S; Brimo F
Arch Pathol Lab Med; 2013 Oct; 137(10):1326-36. PubMed ID: 24079759
[TBL] [Abstract][Full Text] [Related]
28. EZH2 expression is a prognostic factor in childhood intracranial ependymoma: a Canadian Pediatric Brain Tumor Consortium study.
Li AM; Dunham C; Tabori U; Carret AS; McNeely PD; Johnston D; Lafay-Cousin L; Wilson B; Eisenstat DD; Jabado N; Zelcer S; Silva M; Scheinemann K; Fryer C; Hendson G; Fotovati A; Hawkins C; Yip S; Dunn SE; Hukin J
Cancer; 2015 May; 121(9):1499-507. PubMed ID: 25586788
[TBL] [Abstract][Full Text] [Related]
29. Nestin is a wide-spectrum abluminal cell marker of salivary gland tumors.
Yanai H; Sato Y; Nagatsuka H; Yoshino T
Pathol Int; 2013 Oct; 63(10):496-501. PubMed ID: 24147430
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD5 in salivary gland tumors: an ancillary marker for carcinoma showing thymus-like differentiation (CASTLE) of the major salivary gland.
Sasaki E; Terada H; Oishi N; Iwakoshi A; Masago K; Matsushita H; Yamamoto H; Hanai N; Tateyama H
Virchows Arch; 2024 Jun; 484(6):945-950. PubMed ID: 37953373
[TBL] [Abstract][Full Text] [Related]
31. [Malignant pleomorphic adenoma of the salivary gland: a clinicopathological and immunohistochemical study].
Ji XL
Zhonghua Kou Qiang Yi Xue Za Zhi; 1993 Nov; 28(6):353-5, 384. PubMed ID: 8033646
[TBL] [Abstract][Full Text] [Related]
32. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
Wang X; Hu B; Shen H; Zhou H; Xue X; Chen Y; Chen S; Han Y; Yuan B; Zhao H; Zhi Q; Kuang Y
Biomed Pharmacother; 2015 Oct; 75():218-25. PubMed ID: 26271144
[TBL] [Abstract][Full Text] [Related]
33. The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors.
Svedlund J; Barazeghi E; Stålberg P; Hellman P; Åkerström G; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):231-9. PubMed ID: 24292603
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of E-cadherin and zeste homolog 2 expression in endoscopic ultrasound-guided fine-needle aspiration of pancreatic adenocarcinoma.
Gao L; Antic T; Hyjek E; Gong C; Mueller J; Waxman I; DeMay RM; Reeves W
Cancer Cytopathol; 2013 Nov; 121(11):644-52. PubMed ID: 23674382
[TBL] [Abstract][Full Text] [Related]
36. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
37. Expression profile of the polycomb group protein enhancer of Zeste homologue 2 and its prognostic relevance in renal cell carcinoma.
Hinz S; Weikert S; Magheli A; Hoffmann M; Engers R; Miller K; Kempkensteffen C
J Urol; 2009 Dec; 182(6):2920-5. PubMed ID: 19846140
[TBL] [Abstract][Full Text] [Related]
38. Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung.
Bondgaard AL; Poulsen TT; Poulsen HS; Skov BG
Cancer Biomark; 2012; 11(2-3):123-8. PubMed ID: 23011159
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical expression of Bcl-2 in benign and malignant salivary gland tumors.
Manjunatha BS; Kumar GS; Raghunath V
Med Oral Patol Oral Cir Bucal; 2011 Jul; 16(4):e503-7. PubMed ID: 21196881
[TBL] [Abstract][Full Text] [Related]
40. Ancillary testing strategies in salivary gland aspiration cytology: A practical pattern-based approach.
Griffith CC; Siddiqui MT; Schmitt AC
Diagn Cytopathol; 2017 Sep; 45(9):808-819. PubMed ID: 28411379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
